DGAP-News: BioCrea GmbH: BioCrea to Present at BioTrinity

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

May 9, 2014 at 4:15 AM

DGAP-News: BioCrea GmbH: BioCrea to Present at BioTrinity 2014 on 13 May 2014

DGAP-News: BioCrea GmbH / Key word(s): Miscellaneous BioCrea GmbH: BioCrea to Present at BioTrinity 2014 on 13 May 2014 09.05.2014 / 10:00 --------------------------------------------------------------------- Radebeul, Germany, May 09, 2014 - BioCrea GmbH (BioCrea), the first-in-class CNS drug discovery specialist, today announced that Chief Executive Officer, Dr. Tom Kronbach, will present at BioTrinity 2014, Europe's leading Biopartnering and Investment Conference, to be held on 12-14 May in London. Tom Kronbach will be presenting on May 13, 2014 at 13:50 BST in the Alsace Room, Mezzanine Floor, Novotel London West, UK. "This is a wonderful opportunity for BioCrea to present its lead programs and novel discovery platforms to over 30 major pharmaceutical companies," said Dr. Tom Kronbach, CEO of BioCrea. "In partnering terms, we will talk about our two unique proprietary small molecule programs: Long-term acting GABAA positive allosteric modulators (LT GABAA PAMs) to treat epilepsy plus autism; and NMDA receptor 2B (NR2B) negative allosteric modulators (NAMs) to treat depression. Both programs are expected to reach the IND-enabling study phase later this year." Founded and produced by OBN, BioTrinity has become the "must attend" life sciences conference for emerging European companies, investors and partners. The conference is now in its eighth year. BioTrinity has grown rapidly over recent years, and is now located in London to accommodate increased interest. More than 1000 senior executives and decision makers from emerging and established companies across the life sciences sector and investment firms are expected to meet one-on-one, attend panel discussions and workshops, or browse the company showcases, seeking out their next deals. About BioCrea BioCrea, the Radebeul-based first-in-class drug discovery specialist validated through pharma partnerships, has established a number of programs in neurological and psychotic disorders. Its proven expertise is based on proprietary compound libraries, medicinal chemistry, molecular modeling and advanced screening technologies. BioCrea uses this expertise in an innovative multi-parameter optimization approach to generate and deliver CNS drug candidates that offer significant potential for greater efficacy and tolerability. Moreover, the patient-derived stem cell (iPSC) platform has been successfully developed to discover high value preclinical drug candidates for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease). BioCrea was awarded Top Innovator status of the "Top 100" Most Innovative Companies in Germany 2012 by compamedia GmbH. For more information, please visit www.biocrea.com. About OBN OBN is the membership organisation supporting and bringing together the UK's emerging life sciences companies, corporate partners and investors. Our Membership of around 300 companies, spread across the Golden Triangle (formed by the cities of Oxford, Cambridge and London) and beyond to Nottingham, Manchester and Scotland, benefits from tailored networking and partnering events, group purchasing, advice and advocacy. OBN founded and produces BioTrinity, Europe's largest annual Biopartnering and Investment Conference for emerging companies. Attracting around 1,000 senior delegates from Europe, Asia and North America, BioTrinity generates more R&D-company-to-investor interactions than any similar European event. For further information on OBN and its activities, visit: www.obn.org.uk. Contact Dr. Tom Kronbach CEO, BioCrea GmbH Tel.: +49 351 / 4043 3332 Fax: +49 351 / 4043 3216 tom.kronbach@biocrea.com End of Corporate News --------------------------------------------------------------------- 09.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 267460 09.05.2014

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Immunofoco’s Lentiviral Strategy for Cancer Control

Revolutionizing Cancer Treatment: Immunofoco's Approach In the battle against B-cell malignancies, the old ways of doing things sometimes just don’t cut it, folks. Enter Immunofoco. At the recent Society for Immunotherapy of Cancer (SITC) 2026 meeting, they laid some ambitious cards on the table with their in vivo T-cell engager (TCE) delivery strategy. Engineering...

AppLovin Faces Class Action as Promises Fall Short

Class Action Shadows AppLovin Over AI Promises What a tangled web AppLovin has woven for itself. Promises of rapid AI advancements and a slick video tool rollout seemed like a done deal back in the early months of 2026. Well, that was until the cracks started to show by August. Promises Made, Promises Broken The saga kicked off on May 6, 2026, with AppLovin's confident...

Johnine Barnes Joins Prestigious Labor & Employment Fellowship

A Nod to Legal Excellence In the world of labor and employment law, notches on the belt come from more than just winning cases. It's about mastering the balance between legal prowess and professional grace—a cocktail that Johnine P. Barnes seems to have perfected. Just this November, Barnes was elected as a fellow of the College of Labor & Employment Lawyers (CLEL), a...

Claus for a Cause: Respecting Heroes with Holiday Cheer

An Unforgettable Holiday Season Veterans Day isn't just a date on the calendar—it's an opportunity to pause and offer genuine thanks to those who've served with honor. This year, as the holiday season rolls around, Gemmy Industries' Claus for a Cause collection is redefining how we show our appreciation. These aren't your ordinary inflatables; they come with a purpose...

Silicosis Crisis: Legal and Health Ramifications Loom

The Hidden Dangers of Artificial Stone Here's the grim truth. Artificial stone countertops, loved by many for their aesthetics in kitchens and bathrooms, have a dark side that’s becoming increasingly hard to ignore. Loaded with more than 90% respirable crystalline silica, these materials spew out toxic dust when cut or polished. Once that dust gets airborne, workers...

Strauss Group Preps Q3 2026 Earnings Release, Webinar

Earnings Are Around the Corner for Strauss Group This thing's been coming down the pipeline, and now it's official: Strauss Group Ltd. (TASE: STRS) is throwing open the curtain on its third quarter numbers come November 25, 2026. Mark the date, folks: it's a Wednesday. And in this game, timings matter a heap more than you'd think. With the financial world constantly...

Huairen Ceramics: Tech Upgrade Powers Global Aspirations

Tech Revolution in Porcelain's Traditional Hearth Imagine robots glazing porcelain and kilns all on autopilot—that's the new norm at Huairen City, Shanxi Province, home to China's formidable porcelain industry. Gone are the days when craftsmen relied solely on their keen senses to judge the right glaze and firing time. The latest technology has disrupted tradition here,...

Fluence Energy Lawsuit: Investor Unrest Unleashed

The Turbulence Behind FLNC: A Hard Pill to Swallow Looks like Fluence Energy (NASDAQ: FLNC) has stumbled right into a mess that's leaving investors with a bitter aftertaste. A securities class action lawsuit has been thrown their way, shaking up any stability folks thought they had. Levi & Korsinsky, LLP laid down the gauntlet on behalf of the shareholders hoodwinked by...

Real Estate Decisions in Hospitality: Buy or Lease?

Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...

Shipping Stocks Rise Amid Tight Global Tanker Market

Global Tanker Market Challenges Drive Earnings The energy shipping scene's got some heat this quarter, my friends. With crude oil prices getting a decent lift today, some energy shipping players are riding that wave to pretty stellar quarterly results. For those in the know, the global tanker market's choking a bit, making for tight conditions. And when the screws...